Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma.
Baselga E , Dembowska-Baginska B , Przewratil P , González-Enseñat MA , Wyrzykowski D , Torrelo A , López Gutiérrez JC , Rychłowska-Pruszyńska M , de Lucas-Laguna R , Esteve-Martinez A , Roé E , Zaim M , Menon Y , Gautier S , Lebbé G , Bouroubi A , Delaru 
Pediatrics.2018 Aug 06 ; ():.
PubMedで表示
Google翻訳で開く
(6view , 0users)
Full Text Sources
There is no consensus on optimal treatment duration for propranolol in infantile hemangioma (IH). We evaluated the efficacy and safety of oral propranolol solution administered for a minimum of 6 months up to a maximum of 12 months of age in high-risk IH.
PMID: 30082451 [PubMed - as supplied by publisher]
PMID: 30082451 [PubMed - as supplied by publisher]